Burney Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Sell
6,195
-570
-8% -$75.1K 0.02% 392
2026
Q1
$943K Sell
6,765
-683
-9% -$95.6K 0.03% 345
2025
Q4
$914K Buy
7,448
+688
+10% +$83.6K 0.03% 344
2025
Q3
$750K Sell
6,760
-470
-7% -$53.4K 0.02% 352
2025
Q2
$802K Buy
7,230
+721
+11% +$76.7K 0.03% 336
2025
Q1
$729K Sell
6,509
-114
-2% -$11.8K 0.03% 345
2024
Q4
$612K Sell
6,623
-709
-10% -$63.8K 0.02% 390
2024
Q3
$615K Sell
7,332
-915
-11% -$69.8K 0.02% 403
2024
Q2
$566K Sell
8,247
-24,850
-75% -$1.66M 0.02% 400
2024
Q1
$2.42M Sell
33,097
-171
-0.5% -$13.1K 0.09% 205
2023
Q4
$2.69M Buy
33,268
+1,898
+6% +$148K 0.11% 197
2023
Q3
$2.35M Buy
31,370
+37
+0.1% +$2.85K 0.11% 200
2023
Q2
$2.41M Buy
31,333
+82
+0.3% +$6.54K 0.11% 202
2023
Q1
$2.59M Sell
31,251
-2,884
-8% -$239K 0.13% 191
2022
Q4
$2.93M Sell
34,135
-6,677
-16% -$529K 0.15% 164
2022
Q3
$2.52M Sell
40,812
-39,950
-49% -$2.52M 0.14% 173
2022
Q2
$4.99M Buy
80,762
+711
+0.9% +$44K 0.26% 114
2022
Q1
$4.76M Sell
80,051
-1,464
-2% -$93.6K 0.22% 127
2021
Q4
$5.92M Buy
81,515
+6,393
+9% +$440K 0.26% 116
2021
Q3
$5.25M Sell
75,122
-624
-0.8% -$43.8K 0.25% 119
2021
Q2
$5.22M Sell
75,746
-928
-1% -$62K 0.24% 124
2021
Q1
$4.96M Buy
76,674
+918
+1% +$59.2K 0.24% 125
2020
Q4
$4.41M Sell
75,756
-12,904
-15% -$779K 0.24% 127
2020
Q3
$5.6M Sell
88,660
-1,558
-2% -$108K 0.35% 87
2020
Q2
$6.94M Buy
90,218
+7,881
+10% +$604K 0.45% 62
2020
Q1
$6.16M Buy
82,337
+3,148
+4% +$218K 0.47% 67
2019
Q4
$5.15M Sell
79,189
-1,810
-2% -$118K 0.28% 111
2019
Q3
$5.13M Buy
80,999
+20,297
+33% +$1.33M 0.31% 107
2019
Q2
$4.1M Buy
60,702
+9,989
+20% +$657K 0.25% 122
2019
Q1
$3.3M Buy
50,713
+6,306
+14% +$419K 0.2% 149
2018
Q4
$2.78M Sell
44,407
-11
-0% -$769 0.2% 147
2018
Q3
$3.43M Sell
44,418
-10,899
-20% -$823K 0.2% 144
2018
Q2
$3.92M Buy
55,317
+6,590
+14% +$465K 0.23% 128
2018
Q1
$3.67M Sell
48,727
-4,190
-8% -$333K 0.23% 131
2017
Q4
$3.79M Buy
52,917
+7,302
+16% +$555K 0.21% 137
2017
Q3
$3.69M Buy
45,615
+4,551
+11% +$348K 0.24% 129
2017
Q2
$2.91M Sell
41,064
-1,504
-4% -$100K 0.19% 134
2017
Q1
$2.89M Sell
42,568
-4,745
-10% -$334K 0.19% 134
2016
Q4
$3.39M Sell
47,313
-34,778
-42% -$2.58M 0.23% 123
2016
Q3
$6.48M Sell
82,091
-60,800
-43% -$4.94M 0.46% 78
2016
Q2
$11.9M Sell
142,891
-147
-0.1% -$13K 0.86% 33
2016
Q1
$13.1M Buy
143,038
+11,863
+9% +$1.07M 0.96% 27
2015
Q4
$13.3M Buy
131,175
+22,780
+21% +$2.37M 0.99% 28
2015
Q3
$10.6M Buy
108,395
+53,364
+97% +$5.93M 0.82% 38
2015
Q2
$6.44M Buy
55,031
+40,060
+268% +$4.38M 0.44% 78
2015
Q1
$1.47M Buy
14,971
+8,239
+122% +$837K 0.1% 190
2014
Q4
$635K Buy
6,732
+2,547
+61% +$263K 0.05% 247
2014
Q3
$445K Sell
4,185
-475
-10% -$46.5K 0.04% 283
2014
Q2
$386K Sell
4,660
-213
-4% -$16.6K 0.03% 312
2014
Q1
$345K Sell
4,873
-640
-12% -$50.2K 0.03% 316
2013
Q4
$414K Buy
5,513
+270
+5% +$18.8K 0.04% 299
2013
Q3
$330K Sell
5,243
-1,202
-19% -$71.8K 0.04% 328
2013
Q2
$330K Buy
+6,445
New +$336K 0.04% 313

Other funds holding GILD

Burney Company's GILD Position: Q2 2026 in Review

Burney Company reduced its Gilead Sciences (GILD) stake by 8.4% in Q2 2026, selling an estimated $75.1K and leaving 6,195 shares worth $783K. The position accounts for 0.02% of the portfolio, ranked #392.

Burney Company first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q4 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Burney Company held 6,195 shares of Gilead Sciences worth $783K as of Q2 2026.
  • Burney Company sold 570 Gilead Sciences shares in Q2 2026, an estimated $75.1K.
  • Gilead Sciences made up 0.02% of Burney Company's portfolio in Q2 2026, its #392 holding.
  • Burney Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Burney Company's Gilead Sciences position peaked at $13.3M in Q4 2015.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.